Pacific Shuanglin Bio‑Pharm – Market Snapshot and Recent Financial Performance
Stock Symbol: 000403.SZExchange: Shenzhen Stock ExchangeLast Trading Session: 22 Oct 2026, 08:39 PM CETCurrent Price: CNY 9.52Shares Outstanding: 935.4 millionMarket Capitalisation: CNY 9.1 billionAverage Trading Volume (24 h): CNY 39.8 million
Recent Price Action
- The share price was flat (0 %) during the 24 hours ending at 08:39 PM CET.
- Since the close of the previous month, the stock has fallen by 2.89 %.
- The 200‑day simple moving average is CNY 10.39.
- The 52‑week high was CNY 16.42 on 14 Nov 2025; the 52‑week low was CNY 8.54 on 29 Jun 2026.
Latest Quarterly Results (Q3 2026)
- Revenue: Declined compared with the same period in the previous year.
- Operating Income: Year‑to‑date operating income decreased.
- Net Profit: Net profit attributable to shareholders fell markedly; the third‑quarter net profit was significantly lower.
- Cash Flow from Operations: Increased, mainly due to better receivables collection and lower purchase cash outflows.
- Total Assets & Shareholders’ Equity: Both were slightly lower than in the prior year.
- Investment Income & Tax Expense: Both declined, reflecting lower profitability.
- Finance Costs: Increased.
- Board Action: A board meeting was convened to discuss these results and related matters.
Peer Performance (Last 24 Hours)
| Ticker | Trade Status | Current Price | Market Cap (CNY bn) | P/E Ratio |
|---|---|---|---|---|
| 300171.SZ – Tofflon Science & Technolo | Flat (0 %) | 13.59 | 10.9 | 41.38 |
| 002969.SZ – Jiamei Food Packaging Chuz | Flat (0 %) | 9.51 | 10.9 | 84.43 |
| 002092.SZ – Xinjiang Zhongtai Chemical | Flat (0 %) | 4.14 | 10.9 | – |
| 002287.SZ – Tibet Cheezheng Tibetan | Flat (0 %) | 19.02 | 10.9 | 16.33 |
| 600572.SS – Zhejiang Conba Pharmaceuti | Flat (0 %) | 4.18 | 10.9 | 21.34 |
Company Profile
Pacific Shuanglin Bio‑Pharm Co., Ltd. is a Chinese healthcare company headquartered in Zhanjiang, founded in 1996. The firm specializes in the production of blood products, including human albumin, intravenous immunoglobulin, and various immunoglobulins for tetanus and rabies. In addition to pharmaceutical manufacturing, the company engages in biotechnology investment activities. Its shares are listed on the Shenzhen Stock Exchange under the ticker 000403.SZ; the IPO was conducted on 7 June 1996.
